Versant Venture Capital Vii, L.P. Chinook Therapeutics, Inc. (KDNY) insider trading activity

KDNY Quotes by TradingView

Versant Venture Capital Vii, L.P. is > 10% Shareholder of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 2.91 Million shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Apr 04, 2022, when has been sold 709,953 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.91M
0% 3M change
0% 12M change
Total Value Held $0

Versant Venture Capital VII, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2022
SELL
Other acquisition or disposition
-
709,953 Reduced 19.6%
2,913,070 Common Stock
Jan 03 2022
SELL
Open market or private sale
$9,600,000 $16.0 p/Share
600,000 Reduced 14.21%
3,623,023 Common Stock
Aug 27 2021
SELL
Open market or private sale
$7,140,000 $14.0 p/Share
510,000 Reduced 10.78%
4,223,023 Common Stock
VVC

Versant Venture Capital Vii, L.P.

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KDNY